Could a single, smarter surgery spare bladder cancer patients a second operation?
NCT ID NCT05962541
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two approaches for treating non-muscle invasive bladder cancer. The standard approach uses two surgeries: one to remove the tumor and a second to check for leftover cancer. The new approach uses a single, enhanced surgery with a special dye and light to better see and remove all cancer at once. The goal is to see if the single surgery is as safe and effective as the two-step method, potentially saving patients from an extra procedure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AOU Policlinico Umberto I Hospital, UOC Urologia SMUC05, Rome, Italy
RECRUITINGRome, Lazio, 00161, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Bag-Like device pull bladder tumors out whole?
- Could a simple blood or urine test spot bladder cancer earlier?
- Can heated chemotherapy beat bladder cancer without surgery?
- Can a Two-Drug bladder wash beat cancer recurrence?
- Bladder cancer surgery: what happens after the bladder is removed?
- AI eye on bladder cancer: could a smart navigation system help surgeons remove tumors more completely?